HomeAI · summaries
Storia in 2 fonti
GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
Amid a nearly $1 billion GLP-1 manufacturing expansion that began in 2024, CMDO CordenPharma is doubling down on its peptide capacity ambitions. | Amid a nearly $1 billion GLP-1 manufacturing expansion that began in 2024, CMDO CordenPharma is doubling down on its peptide capacity ambitions.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity
CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity
- ·
fiercepharma.com
GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
Amid a nearly $1 billion GLP-1 manufacturing expansion that began in 2024, CMDO CordenPharma is doubling down on its peptide capacity ambitions. | Amid a nearly $1 billion GLP-1…